Welcome to our dedicated page for Tmx Group news (Ticker: TMXXF), a resource for investors and traders seeking the latest updates and insights on Tmx Group stock.
The TMX Group Ltd (TMXXF) news feed on Stock Titan aggregates company disclosures and market-related updates drawn from TMX Group's own announcements. TMX Group describes itself as operating global markets and building digital communities and analytic solutions for businesses, traders and investors, and its news reflects that focus on financial data and stock exchanges.
Regular equity financing statistics releases provide detail on new issuers, initial public offerings, total financings raised and the number of financings on Toronto Stock Exchange and TSX Venture Exchange. These updates also categorize new listings by type, such as Canadian Depositary Receipts, exchange traded products, mining companies, technology companies and special purpose acquisition companies, giving readers insight into the composition of listings on TMX-operated markets.
TMX Group also publishes consolidated trading statistics for its marketplaces, including Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange, Alpha-X, Alpha DRK and Montréal Exchange. These releases summarize trading volume, value and transactions across TMX equities marketplaces, along with derivatives volume and open interest on Montréal Exchange, for each reported period.
Additional news items cover dividend declarations, the release dates and analyst calls for quarterly financial results, and the company's holiday operating schedule for its exchanges and derivatives markets. TMX Group also announces participation by its executives in financial services conferences hosted by major banks. Investors and market participants who follow TMXXF can use this news stream to monitor TMX Group's market activity, corporate actions and communications with the financial community.
TMX Group (OTC:TMXXF) agreed to acquire RAFI Indices from Research Affiliates for US$490 million in total consideration. RAFI Indices reported pro forma run-rate revenue of about US$49 million and adjusted EBITDA of US$38 million as of March 31, 2026.
The deal implies a net valuation of US$393 million after an expected tax benefit with NPV of US$97 million. It will more than triple TMX VettaFi Assets Under Indexing from roughly US$81 billion to US$263 billion, is expected to be accretive to adjusted EPS within 12 months of closing, and will be funded with debt, targeting a pro forma leverage ratio of about 2.7x. Closing is anticipated by the end of Q3 2026, subject to regulatory approval and customary conditions.
Toronto Stock Exchange (TMXXF) welcomed Apotex Health Corp., which begins trading under TSX: APTX on June 10, 2026. Apotex’s IPO is expected to raise $1.3 billion, the largest life sciences IPO in TSX history by total proceeds and among the largest TSX IPOs overall.
Apotex is a Toronto-headquartered global health company with a broad portfolio of generic, biosimilar, branded, and consumer health products, and is described as the largest Canadian-based pharmaceutical company.
TMX Group (OTC:TMXXF) reported May 2026 equity financing statistics for TSX and TSXV. TSX listed 67 new issuers, including 47 ETPs and 15 CDRs, with total financings of $926.6M, up 22% vs April and 5% vs May 2025.
TSXV added four new issuers and raised $1.04B, up 24% month-over-month and 156% year-over-year. Year-to-date, TSX and TSXV total financings reached $8.10B and $6.08B, up 71.7% and 135.4% versus 2025, with higher market caps on both exchanges.
TMX Group (TMXXF) reported May 2026 trading statistics for Toronto Stock Exchange, TSX Venture, TSX Alpha, Alpha-X & Alpha DRK, and Montreal Exchange.
All TMX equities marketplaces recorded May volume of 14.39B shares, value of $413.2B, and 31.0M transactions, with year-to-date volume up 34.9%, value up 37.3%, and transactions up 32.5% versus 2025.
On Toronto Stock Exchange, year-to-date volume reached 53.09B shares and value $2.07T, up 27.4% and 40.4% respectively. TSX Venture year-to-date volume was 25.33B shares and value $25.37B, up 72.2% and 238.3%. Montreal Exchange year-to-date derivatives volume rose 12.6% and open interest 19.1%.
TMX Group (TMXXF) received TSX approval to amend its normal course issuer bid, doubling the maximum repurchase to 5,600,000 common shares, about 2% of 278,232,220 shares outstanding on February 20, 2026.
The bid began February 27, 2026, and now runs to February 26, 2027, with all repurchased shares cancelled and a daily cap of 155,315 shares.
Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange and Montréal Exchange (OTC:TMXXF) will be closed on Monday, May 18, 2026 for Victoria Day. The exchanges will re-open for regular trading on Tuesday, May 19, 2026.
TMX Group (OTC:TMXXF) reported April 2026 equity financing statistics for Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV).
TSX raised $760.4 million in April, down 63% month-over-month and 39% year-over-year, while year-to-date TSX financings rose 87.2% to $7.17 billion.
TSXV April financings totaled $835.7 million, down 56% from March but up 4% year-over-year, with year-to-date financings up 131.5% to $5.05 billion. TSX listed 29 new issuers; TSXV listed 3.
TMX Group (OTC:TMXXF) announced that nominees listed in the management proxy circular were elected as directors at the Annual and Special Meeting held May 5, 2026. Vote tallies for each nominee are reported, with most directors receiving above 97% support; detailed results list votes for and withheld per nominee.
TMX Group (TSX: TMXXF) published April 2026 consolidated trading statistics for TSX, TSX Venture, TSX Alpha (including Alpha-X & Alpha DRK) and Montréal Exchange. April volume was 15.01 billion shares and value was $412.9 billion; year-to-date volume rose +38.5% to 70.22 billion.
All figures are as of April 30, 2026 and may be revised pending trade finalization.
TMX Group (OTC: TMXXF) declared a quarterly cash dividend of $0.24 per common share. The dividend is payable on June 5, 2026 to shareholders of record at the close of business on May 22, 2026. It is designated an eligible dividend for Canadian income tax purposes.